HALOBETASOL PROPIONATE

HALOBETASOL PROPIONATE was reported 1362 times

HALOBETASOL PROPIONATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RADIATION ALOPECIA 2 0.2000
1 HYPNIC HEADACHE 1 0.1250
2 BENIGN NEOPLASM OF CERVIX UTERI 3 0.0882
3 ANALGESIC INTERVENTION SUPPORTIVE THERAPY 1 0.0833
4 CONGENITAL ECTODERMAL DYSPLASIA 1 0.0714
5 HYPERAESTHESIA EYE 1 0.0667
6 DEVICE LEAD ISSUE 1 0.0500
7 CD4 LYMPHOCYTES 1 0.0370
8 SPINAL SYNOVIAL CYST 3 0.0286
9 SKIN SQUAMOUS CELL CARCINOMA RECURRENT 3 0.0263
10 CONGENITAL URETHRAL ANOMALY 1 0.0238
11 TRICHOPHYTOSIS 5 0.0236
12 VASCULAR HYALINOSIS 2 0.0235
13 DRESSLER'S SYNDROME 1 0.0227
14 NONINFECTIVE ENCEPHALITIS 16 0.0223
15 OLIGOARTHRITIS 4 0.0201
16 SQUAMOUS CELL CARCINOMA OF THE VULVA 2 0.0200
17 URINARY CASTS PRESENT 2 0.0190
18 EYES SUNKEN 1 0.0182
19 SPERMATOZOA PROGRESSIVE MOTILITY DECREASED 3 0.0178
20 HAEMANGIOMA OF SKIN 6 0.0138
21 ALCOHOLIC SEIZURE 1 0.0135
22 ANAL FUNGAL INFECTION 1 0.0120
23 PHOTODERMATOSIS 5 0.0118
24 HAND-EYE COORDINATION IMPAIRED 2 0.0118
25 SELF-CONSCIOUSNESS 3 0.0118
26 APPLICATION SITE ECZEMA 1 0.0115
27 POST INFLAMMATORY PIGMENTATION CHANGE 5 0.0110
28 EYE OPACITY 1 0.0109
29 COMPLEMENT FACTOR C4 DECREASED 2 0.0104
30 DYSHIDROSIS 1 0.0104
31 ADRENALECTOMY 1 0.0102
32 LENTIGO 5 0.0101
33 BONE METABOLISM DISORDER 3 0.0100
34 BIRTH MARK 2 0.0096
35 APPLICATION SITE BURNING 1 0.0095
36 BODY TINEA 5 0.0089
37 BENIGN UTERINE NEOPLASM 1 0.0085
38 BILIARY ANASTOMOSIS COMPLICATION 1 0.0083
39 CORONARY OSTIAL STENOSIS 1 0.0079
40 CIRCUMORAL SWELLING 1 0.0078
41 GLOMERULONEPHROPATHY 2 0.0078
42 SEBORRHOEIC KERATOSIS 11 0.0076
43 HEPATITIS B SURFACE ANTIGEN POSITIVE 2 0.0073
44 SYRINGOMYELIA 2 0.0072
45 ENZYME LEVEL ABNORMAL 1 0.0071
46 HISTRIONIC PERSONALITY DISORDER 1 0.0066
47 HISTONE ANTIBODY POSITIVE 1 0.0064
48 CHONDROSARCOMA 1 0.0063
49 DOUBLE STRANDED DNA ANTIBODY POSITIVE 2 0.0061
50 CARCINOMA IN SITU 1 0.0060
51 HAND DERMATITIS 4 0.0058
52 DYSHIDROTIC ECZEMA 4 0.0056
53 WEANING FAILURE 2 0.0055
54 ABDOMINAL HERNIA REPAIR 1 0.0054
55 FRACTURE MALUNION 1 0.0052
56 B PRECURSOR TYPE ACUTE LEUKAEMIA 2 0.0052
57 GLOBOTRIAOSYLSPHINGOSINE INCREASED 1 0.0051
58 ACTINIC KERATOSIS 13 0.0050
59 SUSPECTED COVID-19 16 0.0048
60 HEAVY EXPOSURE TO ULTRAVIOLET LIGHT 1 0.0047
61 HAEMOPHILIA 1 0.0047
62 FRACTURE DISPLACEMENT 2 0.0047
63 NITRITE URINE PRESENT 2 0.0046
64 INFUSION SITE SCAR 2 0.0045
65 ENTHESOPATHY 7 0.0045
66 ECG SIGNS OF MYOCARDIAL ISCHAEMIA 1 0.0044
67 CD4 LYMPHOCYTES INCREASED 1 0.0043
68 BODY MASS INDEX ABNORMAL 1 0.0041
69 DACTYLITIS 4 0.0041
70 CYTOMEGALOVIRUS GASTRITIS 1 0.0040
71 RETINAL INJURY 3 0.0039
72 CHILLBLAINS 1 0.0038
73 GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE 2 0.0038
74 URETHRITIS 2 0.0037
75 HYPERTROPHY 2 0.0037
76 CHOLESTEATOMA 1 0.0036
77 DERMATOPHYTOSIS 1 0.0035
78 BURNS FIRST DEGREE 1 0.0035
79 ENANTHEMA 2 0.0035
80 CARDIAC FUNCTION TEST ABNORMAL 1 0.0034
81 NEOPLASM SKIN 5 0.0032
82 CARBON DIOXIDE ABNORMAL 1 0.0032
83 GLOMERULOSCLEROSIS 2 0.0032
84 BODY MASS INDEX INCREASED 4 0.0030
85 ANION GAP DECREASED 1 0.0029
86 FIBROUS HISTIOCYTOMA 1 0.0028
87 BREAST HYPERPLASIA 1 0.0028
88 ANAESTHESIA 1 0.0027
89 ESSENTIAL THROMBOCYTHAEMIA 1 0.0027
90 CONJUNCTIVAL DISORDER 1 0.0026
91 BILE DUCT STENT INSERTION 1 0.0026
92 ILEITIS 1 0.0026
93 MACULE 7 0.0025
94 BRONCHITIS ACUTE 1 0.0025
95 CAT SCRATCH DISEASE 1 0.0025
96 DEATH OF RELATIVE 1 0.0025
97 GUTTATE PSORIASIS 2 0.0024
98 LUNG HYPERINFLATION 2 0.0023
99 HEART VALVE OPERATION 1 0.0023
100 FUNGAL FOOT INFECTION 1 0.0023
101 INFUSION SITE DISCOLOURATION 2 0.0023
102 RENAL TUBULAR ATROPHY 2 0.0023
103 CARDIAC PACEMAKER REPLACEMENT 1 0.0022
104 IMMUNOGLOBULINS INCREASED 1 0.0021
105 PYURIA 2 0.0020
106 IMPETIGO 3 0.0020
107 HYPOHIDROSIS 1 0.0020
108 SKIN PLAQUE 16 0.0019
109 BLOOD IMMUNOGLOBULIN A INCREASED 1 0.0019
110 BLOOD PH INCREASED 1 0.0018
111 ACUTE SINUSITIS 3 0.0017
112 HAEMATOMA INFECTION 1 0.0017
113 DILATATION ATRIAL 2 0.0017
114 INFUSION SITE DISCHARGE 3 0.0017
115 GLOMERULONEPHRITIS MEMBRANOUS 2 0.0017
116 BLOOD UREA DECREASED 2 0.0016
117 CUTANEOUS T-CELL LYMPHOMA 2 0.0016
118 ANAL INFLAMMATION 1 0.0016
119 INCREASED BRONCHIAL SECRETION 4 0.0016
120 CHALAZION 1 0.0016
121 PAPULE 11 0.0016
122 INFUSION SITE IRRITATION 2 0.0016
123 CELLULITIS STAPHYLOCOCCAL 1 0.0015
124 POLYDIPSIA 6 0.0015
125 DERMATITIS PSORIASIFORM 3 0.0015
126 DISCHARGE 2 0.0014
127 CUSHING'S SYNDROME 1 0.0014
128 ELECTROCARDIOGRAM ST-T CHANGE 1 0.0014
129 BORDERLINE PERSONALITY DISORDER 1 0.0014
130 CD4 LYMPHOCYTES DECREASED 3 0.0014
131 PSORIASIS 183 0.0014
132 CARDIAC SEPTAL DEFECT 1 0.0014
133 RENAL TUBULAR ACIDOSIS 3 0.0014
134 LUMBAR SPINAL STENOSIS 4 0.0014
135 GRANULOMA ANNULARE 1 0.0014
136 FIBROCYSTIC BREAST DISEASE 1 0.0014
137 SQUAMOUS CELL CARCINOMA OF SKIN 8 0.0013
138 BASOPHIL COUNT INCREASED 1 0.0013
139 ROSACEA 6 0.0013
140 PUSTULE 3 0.0013
141 PNEUMONIA LEGIONELLA 2 0.0012
142 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2 0.0012
143 BARRETT'S OESOPHAGUS 1 0.0012
144 CHRONIC HEPATITIS 1 0.0012
145 ANTINUCLEAR ANTIBODY POSITIVE 4 0.0012
146 SKIN FISSURES 24 0.0012
147 FEAR OF FALLING 1 0.0012
148 PITUITARY TUMOUR BENIGN 2 0.0012
149 ERYTHRODERMIC PSORIASIS 1 0.0012
150 DERMATITIS ATOPIC 64 0.0012
151 SEBORRHOEIC DERMATITIS 2 0.0012
152 COLLAPSE OF LUNG 1 0.0012
153 PLANTAR FASCIITIS 4 0.0012
154 HEPATIC FIBROSIS 4 0.0012
155 PUSTULAR PSORIASIS 4 0.0012
156 BLOOD CHLORIDE DECREASED 3 0.0012
157 KIDNEY FIBROSIS 2 0.0012
158 SKIN HAEMORRHAGE 17 0.0011
159 ARTERIAL STENOSIS 1 0.0011
160 SHOULDER ARTHROPLASTY 3 0.0011
161 CALCIPHYLAXIS 2 0.0011
162 FIBROMA 1 0.0011
163 LUPUS NEPHRITIS 2 0.0011
164 SKIN HYPERTROPHY 3 0.0011
165 HEPATIC CONGESTION 1 0.0011
166 DEVICE SAFETY FEATURE ISSUE 1 0.0010
167 HIGH DENSITY LIPOPROTEIN INCREASED 1 0.0010
168 GASTRECTOMY 1 0.0010
169 MUCOSAL DRYNESS 2 0.0010
170 LATENT TUBERCULOSIS 2 0.0010
171 SKIN LESION 26 0.0009
172 NEUROGENIC BLADDER 2 0.0009
173 HYDROCELE 1 0.0009
174 PSORIATIC ARTHROPATHY 38 0.0009
175 ARRHYTHMIA SUPRAVENTRICULAR 1 0.0009
176 ACINETOBACTER INFECTION 1 0.0009
177 GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0009
178 HIGH DENSITY LIPOPROTEIN DECREASED 3 0.0009
179 BENIGN NEOPLASM 1 0.0009
180 CARBON DIOXIDE DECREASED 1 0.0009
181 SKIN ATROPHY 5 0.0009
182 SINUS PAIN 2 0.0009
183 PULMONARY INFARCTION 2 0.0008
184 FULL BLOOD COUNT INCREASED 1 0.0008
185 GRANULOMATOSIS WITH POLYANGIITIS 1 0.0008
186 EYELID SKIN DRYNESS 1 0.0008
187 BLOOD IMMUNOGLOBULIN G INCREASED 1 0.0008
188 GLOMERULONEPHRITIS 2 0.0008
189 HAEMATOCRIT ABNORMAL 1 0.0008
190 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 2 0.0008
191 HYPERAESTHESIA TEETH 1 0.0008
192 TUBERCULIN TEST POSITIVE 2 0.0008
193 DRUG ERUPTION 14 0.0008
194 GASTRIC ULCER PERFORATION 1 0.0008
195 DERMATITIS CONTACT 9 0.0008
196 APPLICATION SITE WARMTH 1 0.0008
197 HEPATIC INFECTION 1 0.0008
198 CANCER PAIN 2 0.0008
199 SEASONAL ALLERGY 11 0.0008
200 APPLICATION SITE EROSION 1 0.0008
201 TENDERNESS 8 0.0008
202 EXFOLIATIVE RASH 2 0.0008
203 PROTEIN TOTAL INCREASED 2 0.0008
204 ECZEMA 39 0.0007
205 SKIN DISCOMFORT 2 0.0007
206 APPLICATION SITE DISCOLOURATION 3 0.0007
207 ARTHRITIS BACTERIAL 3 0.0007
208 RED BLOOD CELL COUNT INCREASED 2 0.0007
209 TRICHORRHEXIS 2 0.0007
210 TEARFULNESS 3 0.0007
211 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
212 SKIN WARM 4 0.0007
213 MELANOCYTIC NAEVUS 3 0.0007
214 BILIARY DILATATION 1 0.0007
215 CREPITATIONS 2 0.0007
216 GANGRENE 4 0.0007
217 SCRATCH 7 0.0007
218 MENISCUS INJURY 4 0.0006
219 PIGMENTATION DISORDER 4 0.0006
220 BLOOD BLISTER 2 0.0006
221 BACTERIAL VAGINOSIS 1 0.0006
222 INAPPROPRIATE AFFECT 1 0.0006
223 TRICUSPID VALVE INCOMPETENCE 5 0.0006
224 SKIN EXFOLIATION 53 0.0006
225 SCIATICA 10 0.0006
226 GLYCOSYLATED HAEMOGLOBIN DECREASED 1 0.0006
227 SCAB 7 0.0006
228 SKIN INJURY 2 0.0006
229 PEPTIC ULCER 2 0.0006
230 GASTRIC DILATATION 1 0.0006
231 DEAFNESS BILATERAL 1 0.0006
232 GAZE PALSY 1 0.0006
233 VARICOSE VEIN 3 0.0006
234 SKIN SWELLING 5 0.0006
235 EXTREMITY NECROSIS 1 0.0006
236 BURNS SECOND DEGREE 1 0.0006
237 ERYTHEMA NODOSUM 2 0.0006
238 AORTIC VALVE STENOSIS 1 0.0006
239 RASH PUSTULAR 4 0.0005
240 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 39 0.0005
241 ESSENTIAL HYPERTENSION 1 0.0005
242 HYPERKERATOSIS 3 0.0005
243 HYPERTRICHOSIS 1 0.0005
244 DIFFUSE ALOPECIA 1 0.0005
245 SNORING 2 0.0005
246 BLOOD BICARBONATE DECREASED 1 0.0005
247 FACE INJURY 2 0.0005
248 CONCOMITANT DISEASE PROGRESSION 1 0.0005
249 MULTIPLE ALLERGIES 4 0.0005
250 VULVOVAGINAL MYCOTIC INFECTION 2 0.0005
251 HYPERLIPIDAEMIA 6 0.0005
252 EYELID PAIN 1 0.0005
253 TRIGGER FINGER 2 0.0005
254 CONJUNCTIVITIS 9 0.0005
255 RED CELL DISTRIBUTION WIDTH INCREASED 2 0.0005
256 EOSINOPHIL COUNT INCREASED 4 0.0005
257 INFUSION SITE SWELLING 3 0.0005
258 ATRIAL TACHYCARDIA 1 0.0005
259 INJECTION SITE DISCOMFORT 5 0.0005
260 INFUSION SITE ERYTHEMA 4 0.0005
261 HEPATIC NEOPLASM MALIGNANT 1 0.0005
262 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 8 0.0005
263 PRODUCT DISPENSING ISSUE 2 0.0005
264 SKIN HYPERPIGMENTATION 4 0.0005
265 CORNEAL DISORDER 1 0.0005
266 SPINAL OSTEOARTHRITIS 4 0.0005
267 PARONYCHIA 2 0.0005
268 DANDRUFF 1 0.0005
269 WHEELCHAIR USER 2 0.0004
270 RHINITIS ALLERGIC 2 0.0004
271 CHOLECYSTITIS CHRONIC 3 0.0004
272 CALCINOSIS 1 0.0004
273 EYE PRURITUS 15 0.0004
274 GOUT 8 0.0004
275 HAEMATOCRIT INCREASED 1 0.0004
276 DENGUE FEVER 1 0.0004
277 DERMATITIS 9 0.0004
278 ARTERIOSCLEROSIS 4 0.0004
279 VAGINAL INFECTION 2 0.0004
280 IMPAIRED QUALITY OF LIFE 6 0.0004
281 DRY SKIN 55 0.0004
282 BRONCHITIS CHRONIC 1 0.0004
283 DERMAL CYST 1 0.0004
284 NASAL POLYPS 2 0.0004
285 APPLICATION SITE BURN 2 0.0004
286 ARTHROPOD BITE 3 0.0004
287 LIGAMENT SPRAIN 4 0.0004
288 PHARYNGITIS 5 0.0004
289 PROTEIN URINE PRESENT 2 0.0004
290 MULTIPLE SCLEROSIS 19 0.0004
291 DERMATOMYOSITIS 1 0.0004
292 AORTIC ANEURYSM 3 0.0004
293 ENDODONTIC PROCEDURE 1 0.0004
294 EXCORIATION 1 0.0004
295 DYSLIPIDAEMIA 2 0.0004
296 DRUG DELIVERY SYSTEM MALFUNCTION 2 0.0004
297 INCREASED UPPER AIRWAY SECRETION 2 0.0004
298 LOW DENSITY LIPOPROTEIN INCREASED 3 0.0004
299 CONCUSSION 3 0.0004
300 DRUG TITRATION ERROR 1 0.0004
301 HERNIA REPAIR 1 0.0004
302 PRODUCT USE IN UNAPPROVED INDICATION 95 0.0004
303 SENSITIVITY TO WEATHER CHANGE 2 0.0004
304 FURUNCLE 3 0.0004
305 FULL BLOOD COUNT ABNORMAL 4 0.0004
306 BLOOD ALBUMIN DECREASED 3 0.0004
307 OBESITY 6 0.0004
308 TREATMENT FAILURE 31 0.0004
309 QUALITY OF LIFE DECREASED 5 0.0004
310 RHINITIS 3 0.0004
311 CHEILITIS 2 0.0004
312 CHONDROPATHY 1 0.0004
313 EAR CONGESTION 1 0.0004
314 CLUMSINESS 1 0.0004
315 HYPERAESTHESIA 3 0.0004
316 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
317 ORAL HERPES 7 0.0004
318 ANGIOPATHY 2 0.0004
319 PRODUCT LEAKAGE 2 0.0004
320 REBOUND EFFECT 4 0.0004
321 MITRAL VALVE INCOMPETENCE 4 0.0004
322 PRODUCT CONTAINER ISSUE 3 0.0003
323 CARDIAC VALVE DISEASE 2 0.0003
324 CARDIAC MURMUR 3 0.0003
325 BLOOD URIC ACID INCREASED 2 0.0003
326 UPPER RESPIRATORY TRACT INFECTION 16 0.0003
327 EYELID MARGIN CRUSTING 1 0.0003
328 RALES 2 0.0003
329 ANHEDONIA 9 0.0003
330 IMMUNODEFICIENCY 5 0.0003
331 PAIN OF SKIN 9 0.0003
332 SYMPTOM RECURRENCE 2 0.0003
333 ACNE CYSTIC 1 0.0003
334 LUPUS-LIKE SYNDROME 3 0.0003
335 PRURITUS 127 0.0003
336 HIDRADENITIS 3 0.0003
337 PNEUMONIA BACTERIAL 3 0.0003
338 UROSEPSIS 3 0.0003
339 INFUSION SITE EXTRAVASATION 2 0.0003
340 FOREIGN BODY IN THROAT 1 0.0003
341 BLADDER PAIN 1 0.0003
342 SLEEP APNOEA SYNDROME 6 0.0003
343 GALACTORRHOEA 2 0.0003
344 HAEMOGLOBIN ABNORMAL 2 0.0003
345 BRONCHITIS 23 0.0003
346 INFUSION SITE PAIN 4 0.0003
347 ANGINA UNSTABLE 2 0.0003
348 OSTEOARTHRITIS 13 0.0003
349 BRADYPHRENIA 2 0.0003
350 BREAST ENLARGEMENT 1 0.0003
351 ORAL CANDIDIASIS 4 0.0003
352 THERAPEUTIC RESPONSE SHORTENED 10 0.0003
353 DRY EYE 15 0.0003
354 ANXIETY DISORDER 1 0.0003
355 BREAST MASS 2 0.0003
356 SLEEP DISORDER 21 0.0003
357 HEPATIC FUNCTION ABNORMAL 11 0.0003
358 B-CELL LYMPHOMA 1 0.0003
359 RASH ERYTHEMATOUS 14 0.0003
360 MATERNAL EXPOSURE BEFORE PREGNANCY 2 0.0003
361 EYE DISCHARGE 3 0.0003
362 PULMONARY HYPERTENSION 6 0.0003
363 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
364 CAROTID ARTERY STENOSIS 1 0.0003
365 WOUND 8 0.0003
366 FOLLICULITIS 3 0.0003
367 RASH MACULAR 10 0.0003
368 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
369 GLOSSITIS 1 0.0003
370 FIBRIN D DIMER INCREASED 1 0.0003
371 HAEMORRHAGIC DIATHESIS 1 0.0003
372 FEAR OF INJECTION 2 0.0003
373 APPENDICECTOMY 1 0.0003
374 FRUSTRATION 1 0.0003
375 BONE LESION 1 0.0003
376 CHRONIC GRAFT VERSUS HOST DISEASE 1 0.0003
377 RESTLESS LEGS SYNDROME 5 0.0003
378 CAROTID ARTERY OCCLUSION 1 0.0003
379 UTERINE LEIOMYOMA 2 0.0003
380 ORAL DISORDER 2 0.0003
381 APPLICATION SITE PAIN 6 0.0003
382 RED BLOOD CELL SEDIMENTATION RATE INCREASED 3 0.0003
383 SENSITIVE SKIN 2 0.0003
384 FREEZING PHENOMENON 1 0.0003
385 FUNGAL INFECTION 9 0.0003
386 SKIN DISORDER 9 0.0003
387 PULMONARY MASS 4 0.0003
388 HEPATIC STEATOSIS 5 0.0003
389 SUNBURN 2 0.0003
390 SKIN INFECTION 3 0.0003
391 JOINT STIFFNESS 7 0.0003
392 BLOOD CALCIUM DECREASED 3 0.0003
393 CHRONIC SINUSITIS 1 0.0003
394 HEPATIC NECROSIS 1 0.0003
395 PEMPHIGOID 2 0.0003
396 AUTOIMMUNE THYROIDITIS 1 0.0003
397 ECONOMIC PROBLEM 4 0.0003
398 EAR INFECTION 7 0.0003
399 CHOLECYSTECTOMY 3 0.0003
400 FEELING JITTERY 5 0.0003
401 SKIN IRRITATION 12 0.0003
402 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
403 GINGIVAL DISORDER 1 0.0003
404 ACCIDENT 3 0.0003
405 CEREBRAL ATROPHY 1 0.0003
406 OROPHARYNGEAL PAIN 23 0.0002
407 FUNGAL SKIN INFECTION 1 0.0002
408 THERAPEUTIC RESPONSE DECREASED 15 0.0002
409 NOCTURIA 3 0.0002
410 FIBROMYALGIA 6 0.0002
411 HOMICIDAL IDEATION 1 0.0002
412 HYPERPYREXIA 1 0.0002
413 AORTIC VALVE INCOMPETENCE 1 0.0002
414 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
415 ABSCESS LIMB 1 0.0002
416 JOINT INJURY 5 0.0002
417 VITAMIN D DECREASED 2 0.0002
418 SCAR 4 0.0002
419 LIVER FUNCTION TEST INCREASED 5 0.0002
420 CARDIAC OPERATION 2 0.0002
421 ABNORMAL SENSATION IN EYE 1 0.0002
422 DEVICE OPERATIONAL ISSUE 1 0.0002
423 ANURIA 2 0.0002
424 BLISTER 13 0.0002
425 HEPATIC LESION 1 0.0002
426 BONE CANCER 1 0.0002
427 IMMOBILE 1 0.0002
428 BURNING SENSATION 16 0.0002
429 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
430 SINUSITIS 23 0.0002
431 FACIAL PAIN 2 0.0002
432 JOINT RANGE OF MOTION DECREASED 3 0.0002
433 HAEMOLYTIC ANAEMIA 2 0.0002
434 OSTEOMYELITIS 4 0.0002
435 DRUG TOXICITY 3 0.0002
436 CORONARY ARTERY OCCLUSION 3 0.0002
437 CELLULITIS 11 0.0002
438 RASH 95 0.0002
439 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
440 ARTHRITIS INFECTIVE 1 0.0002
441 GASTRITIS EROSIVE 1 0.0002
442 STOMATITIS 13 0.0002
443 DISCOMFORT 13 0.0002
444 BLOOD SODIUM DECREASED 4 0.0002
445 BLOOD PROLACTIN INCREASED 1 0.0002
446 PRODUCT DOSE OMISSION IN ERROR 6 0.0002
447 PRODUCT PRESCRIBING ERROR 5 0.0002
448 ENDOMETRIOSIS 1 0.0002
449 ERYTHEMA 43 0.0002
450 HYPERCHOLESTEROLAEMIA 2 0.0002
451 GUILLAIN-BARRE SYNDROME 1 0.0002
452 FINGER DEFORMITY 1 0.0002
453 DIZZINESS POSTURAL 2 0.0002
454 MUSCULOSKELETAL STIFFNESS 18 0.0002
455 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
456 VITAMIN D DEFICIENCY 2 0.0002
457 DRUG INEFFECTIVE 270 0.0002
458 PHARYNGEAL SWELLING 2 0.0002
459 INJECTION SITE URTICARIA 5 0.0002
460 HEPATOMEGALY 2 0.0002
461 KNEE OPERATION 2 0.0002
462 RASH PRURITIC 11 0.0002
463 HOSPICE CARE 2 0.0002
464 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
465 HYPERVOLAEMIA 1 0.0002
466 FOOT OPERATION 1 0.0002
467 INABILITY TO AFFORD MEDICATION 2 0.0002
468 PERIPHERAL SWELLING 31 0.0002
469 ANEURYSM 1 0.0002
470 APPLICATION SITE SWELLING 1 0.0002
471 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 11 0.0002
472 CORONARY ARTERY STENOSIS 1 0.0002
473 DRUG TOLERANCE 1 0.0002
474 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
475 DEVICE FAILURE 3 0.0002
476 HIP ARTHROPLASTY 3 0.0002
477 THYROID DISORDER 3 0.0002
478 TEMPERATURE INTOLERANCE 2 0.0002
479 SKIN ULCER 5 0.0002
480 VENTRICULAR EXTRASYSTOLES 2 0.0002
481 COUGH 54 0.0002
482 C-REACTIVE PROTEIN INCREASED 7 0.0002
483 BRAIN FOG 3 0.0002
484 KNEE ARTHROPLASTY 4 0.0002
485 JOINT DISLOCATION 2 0.0002
486 CONDITION AGGRAVATED 57 0.0002
487 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 9 0.0002
488 MOVEMENT DISORDER 6 0.0002
489 COMPRESSION FRACTURE 1 0.0002
490 ANAL FISSURE 1 0.0002
491 SKIN CANCER 4 0.0002
492 WHEEZING 11 0.0002
493 BRUXISM 1 0.0002
494 DECREASED ACTIVITY 2 0.0002
495 BLOOD POTASSIUM INCREASED 3 0.0002
496 SKIN LACERATION 2 0.0002
497 OESOPHAGITIS 2 0.0002
498 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
499 COVID-19 32 0.0002
500 THERAPEUTIC PRODUCT EFFECT DECREASED 8 0.0002
501 SNEEZING 4 0.0002
502 OCULAR DISCOMFORT 2 0.0002
503 THERAPY NON-RESPONDER 8 0.0002
504 CANDIDA INFECTION 3 0.0002
505 GAIT DISTURBANCE 34 0.0002
506 FLUID RETENTION 9 0.0002
507 PRODUCT AVAILABILITY ISSUE 4 0.0002
508 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
509 EPISTAXIS 13 0.0002
510 EXERCISE TOLERANCE DECREASED 1 0.0002
511 METASTASES TO LUNG 2 0.0002
512 CAESAREAN SECTION 2 0.0002
513 NEEDLE ISSUE 5 0.0002
514 HYPOVOLAEMIA 1 0.0002
515 LYMPHOCYTE COUNT DECREASED 3 0.0002
516 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
517 BRADYKINESIA 1 0.0002
518 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
519 POLLAKIURIA 7 0.0002
520 CARDIAC PACEMAKER INSERTION 1 0.0002
521 MUSCULAR WEAKNESS 19 0.0002
522 GASTROENTERITIS VIRAL 3 0.0002
523 TOOTHACHE 3 0.0002
524 JOINT SWELLING 20 0.0002
525 HEPATITIS C 2 0.0002
526 PRODUCT DOSE OMISSION ISSUE 48 0.0002
527 DRUG ABUSER 1 0.0002
528 CARDIOMEGALY 2 0.0002
529 PALPITATIONS 19 0.0002
530 ARTHROPATHY 9 0.0002
531 ABNORMAL WEIGHT GAIN 2 0.0002
532 ABASIA 4 0.0002
533 EYE SWELLING 6 0.0002
534 CYST 2 0.0002
535 ARTHRALGIA 67 0.0002
536 ILEUS 2 0.0002
537 MULTIPLE SCLEROSIS RELAPSE 11 0.0002
538 AGEUSIA 4 0.0002
539 DERMATITIS ALLERGIC 2 0.0002
540 FOOT FRACTURE 3 0.0002
541 MUSCLE ATROPHY 2 0.0002
542 PROTEINURIA 3 0.0002
543 INJECTION SITE SWELLING 12 0.0002
544 PAIN IN EXTREMITY 46 0.0002
545 ROTATOR CUFF SYNDROME 2 0.0002
546 HERNIA 3 0.0002
547 EXPOSURE VIA SKIN CONTACT 4 0.0002
548 DRUG SPECIFIC ANTIBODY PRESENT 1 0.0002
549 INJECTION SITE PAIN 47 0.0002
550 MUSCLE SPASMS 28 0.0002
551 SKIN DISCOLOURATION 7 0.0002
552 HYPOGAMMAGLOBULINAEMIA 1 0.0002
553 IMMUNE SYSTEM DISORDER 2 0.0002
554 ANKYLOSING SPONDYLITIS 2 0.0002
555 TOOTH INFECTION 2 0.0002
556 SINUS DISORDER 3 0.0002
557 SARS-COV-2 TEST POSITIVE 2 0.0002
558 CORONAVIRUS INFECTION 1 0.0002
559 GAIT INABILITY 5 0.0001
560 URTICARIA 25 0.0001
561 COLITIS ISCHAEMIC 1 0.0001
562 HYPERSENSITIVITY 27 0.0001
563 HAIR GROWTH ABNORMAL 1 0.0001
564 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 26 0.0001
565 AUTOIMMUNE HEPATITIS 1 0.0001
566 FORMICATION 1 0.0001
567 CARPAL TUNNEL SYNDROME 2 0.0001
568 HYPOXIA 5 0.0001
569 SKIN REACTION 2 0.0001
570 EYE PAIN 8 0.0001
571 PAIN IN JAW 4 0.0001
572 HAND FRACTURE 1 0.0001
573 SINUS TACHYCARDIA 2 0.0001
574 DIVERTICULUM 1 0.0001
575 INTENTIONAL DOSE OMISSION 4 0.0001
576 HYPERSOMNIA 4 0.0001
577 INJECTION SITE BRUISING 11 0.0001
578 BACK PAIN 32 0.0001
579 PRODUCT PRESCRIBING ISSUE 3 0.0001
580 DRUG EFFECT INCOMPLETE 5 0.0001
581 ILLNESS 14 0.0001
582 BLINDNESS TRANSIENT 1 0.0001
583 CARDIOMYOPATHY 2 0.0001
584 HYPOPHOSPHATAEMIA 1 0.0001
585 INJECTION SITE PRURITUS 9 0.0001
586 RASH PAPULAR 3 0.0001
587 RESPIRATORY DISORDER 4 0.0001
588 HYDRONEPHROSIS 1 0.0001
589 APHASIA 4 0.0001
590 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
591 CORONARY ARTERY DISEASE 4 0.0001
592 ACNE 10 0.0001
593 OSTEOPENIA 2 0.0001
594 CHRONIC KIDNEY DISEASE 10 0.0001
595 HEPATOCELLULAR CARCINOMA 1 0.0001
596 OEDEMA PERIPHERAL 16 0.0001
597 ABDOMINAL DISCOMFORT 22 0.0001
598 INSURANCE ISSUE 2 0.0001
599 PHARYNGEAL OEDEMA 2 0.0001
600 HAEMOLYSIS 1 0.0001
601 ATRIOVENTRICULAR BLOCK 1 0.0001
602 CONGENITAL ANOMALY 1 0.0001
603 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
604 URINARY TRACT INFECTION 22 0.0001
605 APHTHOUS ULCER 1 0.0001
606 PAIN 79 0.0001
607 THERAPY PARTIAL RESPONDER 2 0.0001
608 ARTHRITIS 10 0.0001
609 HAEMATOCHEZIA 7 0.0001
610 OCULAR HYPERAEMIA 6 0.0001
611 RESPIRATORY TRACT CONGESTION 2 0.0001
612 ULCER 2 0.0001
613 PRODUCTIVE COUGH 6 0.0001
614 GINGIVAL PAIN 1 0.0001
615 ATRIAL FLUTTER 1 0.0001
616 HYPOTHYROIDISM 4 0.0001
617 NIGHT SWEATS 4 0.0001
618 LOCALISED INFECTION 3 0.0001
619 FRUSTRATION TOLERANCE DECREASED 1 0.0001
620 FLATULENCE 7 0.0001
621 DEEP VEIN THROMBOSIS 8 0.0001
622 SWELLING FACE 8 0.0001
623 CEREBRAL INFARCTION 3 0.0001
624 CHOLELITHIASIS 4 0.0001
625 HICCUPS 1 0.0001
626 OSTEOPOROSIS 5 0.0001
627 INJECTION SITE ERYTHEMA 15 0.0001
628 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
629 ACUTE CORONARY SYNDROME 1 0.0001
630 EXPIRED PRODUCT ADMINISTERED 4 0.0001
631 CHEST DISCOMFORT 12 0.0001
632 RECTAL HAEMORRHAGE 5 0.0001
633 INFLAMMATION 6 0.0001
634 MUSCULOSKELETAL DISCOMFORT 2 0.0001
635 RASH GENERALISED 3 0.0001
636 EMOTIONAL DISTRESS 14 0.0001
637 RESPIRATORY TRACT INFECTION 3 0.0001
638 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 6 0.0001
639 LOCAL SWELLING 2 0.0001
640 AMENORRHOEA 2 0.0001
641 BLOOD CALCIUM INCREASED 1 0.0001
642 GROIN PAIN 1 0.0001
643 GRIP STRENGTH DECREASED 1 0.0001
644 LYMPHADENOPATHY 4 0.0001
645 ATRIAL FIBRILLATION 11 0.0001
646 GALLBLADDER DISORDER 2 0.0001
647 GASTROINTESTINAL DISORDER 10 0.0001
648 BLOOD BILIRUBIN INCREASED 3 0.0001
649 SYNOVITIS 2 0.0001
650 LIMB INJURY 3 0.0001
651 GASTROINTESTINAL CARCINOMA 1 0.0001
652 END STAGE RENAL DISEASE 2 0.0001
653 EXOSTOSIS 1 0.0001
654 VISION BLURRED 15 0.0001
655 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
656 RESPIRATORY DISTRESS 3 0.0001
657 ANAPHYLACTIC REACTION 6 0.0001
658 PRODUCT DOSE OMISSION 7 0.0001
659 APPENDICITIS 1 0.0001
660 DIARRHOEA HAEMORRHAGIC 1 0.0001
661 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
662 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
663 PHOTOPHOBIA 2 0.0001
664 DYSPHAGIA 10 0.0001
665 PULMONARY EMBOLISM 10 0.0001
666 RED BLOOD CELL COUNT DECREASED 3 0.0001
667 PULMONARY FIBROSIS 2 0.0001
668 EYE IRRITATION 6 0.0001
669 ACUTE RESPIRATORY FAILURE 2 0.0001
670 AFFECT LABILITY 1 0.0001
671 CONTUSION 10 0.0001
672 ATELECTASIS 1 0.0001
673 LIVER FUNCTION TEST ABNORMAL 3 0.0001
674 NASOPHARYNGITIS 19 0.0001
675 EAR PAIN 2 0.0001
676 DYSSTASIA 3 0.0001
677 HEPATIC ENZYME INCREASED 7 0.0001
678 CHILLS 12 0.0001
679 NASAL CONGESTION 6 0.0001
680 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
681 ACUTE MYOCARDIAL INFARCTION 3 0.0001
682 INJECTION SITE REACTION 7 0.0001
683 HAEMATOCRIT DECREASED 2 0.0001
684 CATARACT 6 0.0001
685 BLADDER DISORDER 1 0.0001
686 FATIGUE 78 0.0001
687 INJECTION SITE HAEMORRHAGE 8 0.0001
688 BRAIN INJURY 1 0.0001
689 LACRIMATION INCREASED 3 0.0001
690 PRODUCT PHYSICAL ISSUE 2 0.0001
691 EMPHYSEMA 1 0.0001
692 FEEDING DISORDER 2 0.0001
693 DRY THROAT 1 0.0001
694 BODY TEMPERATURE INCREASED 2 0.0001
695 FEELING HOT 6 0.0001
696 ALANINE AMINOTRANSFERASE INCREASED 6 0.0001
697 PRODUCT PREPARATION ERROR 2 0.0001
698 INJECTION SITE WARMTH 2 0.0001
699 LIMB DISCOMFORT 3 0.0001
700 SWELLING 9 0.0001
701 MOUTH ULCERATION 2 0.0001
702 DEPRESSED MOOD 5 0.0001
703 BODY HEIGHT DECREASED 1 0.0001
704 DRUG INTOLERANCE 9 0.0001
705 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
706 WHITE BLOOD CELL COUNT DECREASED 10 0.0001
707 FAECES DISCOLOURED 2 0.0001
708 BIPOLAR DISORDER 1 0.0001
709 PRODUCT STORAGE ERROR 8 0.0001
710 BLOOD GLUCOSE FLUCTUATION 1 0.0001
711 GASTROINTESTINAL PAIN 1 0.0001
712 PRODUCT USE ISSUE 17 0.0001
713 VISUAL ACUITY REDUCED 3 0.0001
714 VIRAL INFECTION 3 0.0001
715 LIP SWELLING 3 0.0001
716 STEVENS-JOHNSON SYNDROME 2 0.0001
717 INFECTION 13 0.0001
718 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
719 EYE INFECTION 1 0.0001
720 HEADACHE 55 0.0001
721 HAEMOGLOBIN DECREASED 9 0.0001
722 HAEMATURIA 3 0.0001
723 NEPHROLITHIASIS 4 0.0001
724 HERPES ZOSTER 5 0.0001
725 GASTROOESOPHAGEAL REFLUX DISEASE 7 0.0001
726 ALOPECIA 17 0.0001
727 PNEUMONIA 28 0.0001
728 CHEST PAIN 16 0.0001
729 EYELID OEDEMA 1 0.0001
730 RENAL DISORDER 4 0.0001
731 BLOOD CHOLESTEROL INCREASED 4 0.0001
732 DYSPHONIA 5 0.0001
733 HYPERHIDROSIS 11 0.0001
734 SURGERY 5 0.0001
735 ARRHYTHMIA 4 0.0001
736 MALAISE 37 0.0001
737 ANXIETY 24 0.0001
738 NEUROPATHY PERIPHERAL 8 0.0001
739 DRUG ABUSE 7 0.0001
740 THERAPY INTERRUPTED 6 0.0001
741 CHOLECYSTITIS 1 0.0001
742 SKIN BURNING SENSATION 6 0.0001
743 MENTAL IMPAIRMENT 2 0.0001
744 RESPIRATORY FAILURE 6 0.0001
745 DIARRHOEA 53 0.0001
746 INJECTION SITE MASS 3 0.0001
747 HYPERCALCAEMIA 1 0.0001
748 BALANCE DISORDER 7 0.0001
749 GENERALISED OEDEMA 1 0.0001
750 PNEUMONIA ASPIRATION 2 0.0001
751 BRAIN OEDEMA 1 0.0001
752 DEPRESSION 18 0.0001
753 ABDOMINAL PAIN LOWER 2 0.0001
754 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
755 RHINORRHOEA 5 0.0001
756 PHARMACEUTICAL PRODUCT COMPLAINT 2 0.0001
757 BLOOD CREATININE INCREASED 5 0.0001
758 DEAFNESS 2 0.0001
759 PARAESTHESIA 12 0.0001
760 INCORRECT PRODUCT STORAGE 1 0.0001
761 DISORIENTATION 3 0.0001
762 HYPERTENSION 16 0.0001
763 DYSMENORRHOEA 1 0.0001
764 FALL 25 0.0001
765 INSOMNIA 20 0.0001
766 BREAST CANCER FEMALE 2 0.0001
767 HAIR TEXTURE ABNORMAL 1 0.0001
768 INCORRECT DOSE ADMINISTERED 17 0.0001
769 FREQUENT BOWEL MOVEMENTS 2 0.0001
770 DRY MOUTH 6 0.0001
771 DEVICE BREAKAGE 3 0.0001
772 IMPAIRED GASTRIC EMPTYING 1 0.0001
773 GINGIVAL BLEEDING 1 0.0001
774 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
775 DIVERTICULITIS 2 0.0001
776 BLOOD PRESSURE INCREASED 11 0.0001
777 FEELING COLD 2 0.0001
778 HYPOMAGNESAEMIA 1 0.0001
779 ASTHENIA 27 0.0001
780 CARDIO-RESPIRATORY ARREST 3 0.0001
781 INFLUENZA 8 0.0001
782 ROAD TRAFFIC ACCIDENT 3 0.0001
783 HAEMOPTYSIS 2 0.0001
784 APHONIA 1 0.0001
785 DEMENTIA 2 0.0001
786 HEART RATE INCREASED 7 0.0001
787 BRONCHOSPASM 1 0.0001
788 ANGINA PECTORIS 2 0.0001
789 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
790 MENTAL DISORDER 3 0.0001
791 DECREASED APPETITE 16 0.0001
792 HYPOKINESIA 1 0.0001
793 INTENTIONAL PRODUCT MISUSE 6 0.0001
794 GASTROENTERITIS 1 0.0001
795 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
796 WEIGHT DECREASED 19 0.0001
797 ASCITES 2 0.0001
798 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001
799 LABORATORY TEST ABNORMAL 2 0.0001
800 URINARY INCONTINENCE 2 0.0001
801 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
802 BLOOD POTASSIUM DECREASED 2 0.0001
803 DIZZINESS 33 0.0001
804 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
805 PLEURAL EFFUSION 4 0.0001
806 NAUSEA 52 0.0001
807 PLATELET COUNT DECREASED 7 0.0001
808 DRUG DISPENSING ERROR 1 0.0001
809 DYSPNOEA 37 0.0001
810 ACUTE KIDNEY INJURY 10 0.0001
811 TINNITUS 3 0.0001
812 OFF LABEL USE 57 0.0001
813 DEVICE RELATED INFECTION 1 0.0001
814 ANKLE FRACTURE 1 0.0001
815 DELUSION 1 0.0001
816 EJECTION FRACTION DECREASED 1 0.0001
817 COGNITIVE DISORDER 3 0.0001
818 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 3 0.0001
819 CONSTIPATION 14 0.0001
820 CARDIAC DISORDER 6 0.0001
821 BASAL CELL CARCINOMA 1 0.0001
822 CYANOSIS 1 0.0001
823 HEAD INJURY 2 0.0001
824 ABDOMINAL PAIN UPPER 13 0.0001
825 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
826 MIGRAINE 6 0.0001
827 SEPSIS 7 0.0001
828 CARDIAC FAILURE CONGESTIVE 5 0.0001
829 BACK DISORDER 1 0.0001
830 IMPAIRED HEALING 2 0.0001
831 OSTEONECROSIS 2 0.0001
832 RENAL FAILURE 8 0.0001
833 BLOOD PRESSURE DECREASED 4 0.0001
834 HYPOAESTHESIA 9 0.0001
835 LEUKOPENIA 3 0.0001
836 BLOOD UREA INCREASED 1 0.0001
837 FACE OEDEMA 1 0.0001
838 MYALGIA 10 0.0001
839 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
840 GASTRIC DISORDER 2 0.0001
841 DELIRIUM 2 0.0001
842 HAEMORRHAGE 6 0.0001
843 MYOCARDIAL INFARCTION 10 0.0001
844 MUSCULOSKELETAL PAIN 3 0.0001
845 DEVICE USE ISSUE 1 0.0001
846 HYPERKALAEMIA 2 0.0001
847 HEART RATE DECREASED 2 0.0001
848 INJURY 4 0.0001
849 COLD SWEAT 1 0.0001
850 VISUAL IMPAIRMENT 7 0.0001
851 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
852 TACHYCARDIA 5 0.0001
853 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
854 ADVERSE DRUG REACTION 5 0.0001
855 OEDEMA 3 0.0001
856 VOMITING 26 0.0001
857 BONE DISORDER 1 0.0001
858 TREATMENT NONCOMPLIANCE 3 0.0001
859 SUICIDAL IDEATION 5 0.0001
860 AGITATION 4 0.0001
861 MEDICATION ERROR 3 0.0001
862 BACTERIAL INFECTION 1 0.0001
863 DYSPNOEA EXERTIONAL 2 0.0001
864 FRACTURE 1 0.0001
865 BLOOD URINE PRESENT 1 0.0001
866 CONVULSION 3 0.0001
867 DRUG PRESCRIBING ERROR 1 0.0001
868 GLAUCOMA 1 0.0001
869 ERUCTATION 1 0.0001
870 ABDOMINAL PAIN 12 0.0001
871 DYSTONIA 1 0.0001
872 DISABILITY 1 0.0001
873 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
874 BLOOD PRESSURE ABNORMAL 1 0.0001
875 HYPOTENSION 10 0.0000
876 FULL BLOOD COUNT DECREASED 1 0.0000
877 ILL-DEFINED DISORDER 3 0.0000
878 EXTRA DOSE ADMINISTERED 2 0.0000
879 VERTIGO 3 0.0000
880 PYREXIA 17 0.0000
881 NEUTROPHIL COUNT DECREASED 2 0.0000
882 INFLUENZA LIKE ILLNESS 4 0.0000
883 TREMOR 8 0.0000
884 RHABDOMYOLYSIS 2 0.0000
885 ABDOMINAL DISTENSION 5 0.0000
886 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
887 RENAL IMPAIRMENT 4 0.0000
888 EATING DISORDER 1 0.0000
889 LOSS OF CONSCIOUSNESS 6 0.0000
890 IMPAIRED WORK ABILITY 1 0.0000
891 HYPOACUSIS 2 0.0000
892 AMNESIA 3 0.0000
893 DEVICE DISLOCATION 2 0.0000
894 FEELING ABNORMAL 11 0.0000
895 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
896 NEOPLASM MALIGNANT 3 0.0000
897 PULMONARY OEDEMA 2 0.0000
898 DEVICE ISSUE 4 0.0000
899 THROAT IRRITATION 2 0.0000
900 CHROMATURIA 1 0.0000
901 HEART RATE IRREGULAR 1 0.0000
902 ASTHMA 5 0.0000
903 DRUG INTERACTION 7 0.0000
904 MEMORY IMPAIRMENT 6 0.0000
905 HYPOKALAEMIA 2 0.0000
906 CONFUSIONAL STATE 7 0.0000
907 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
908 BREAST CANCER 4 0.0000
909 DISEASE PROGRESSION 5 0.0000
910 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
911 BLOOD PRESSURE FLUCTUATION 1 0.0000
912 HEPATIC CANCER 1 0.0000
913 CEREBROVASCULAR ACCIDENT 7 0.0000
914 HYPOGLYCAEMIA 2 0.0000
915 LUNG DISORDER 2 0.0000
916 DYSPEPSIA 4 0.0000
917 WEIGHT INCREASED 9 0.0000
918 SYNCOPE 4 0.0000
919 HOT FLUSH 3 0.0000
920 HAEMATEMESIS 1 0.0000
921 FLUSHING 4 0.0000
922 HYPOPHAGIA 1 0.0000
923 NERVOUSNESS 2 0.0000
924 APPLICATION SITE ERYTHEMA 1 0.0000
925 PANCREATITIS 2 0.0000
926 BRADYCARDIA 2 0.0000
927 THROMBOSIS 3 0.0000
928 BLOOD GLUCOSE INCREASED 7 0.0000
929 DRUG EFFECT DECREASED 2 0.0000
930 DISTURBANCE IN ATTENTION 2 0.0000
931 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
932 DRUG DOSE OMISSION 6 0.0000
933 ABNORMAL DREAMS 1 0.0000
934 NECK PAIN 2 0.0000
935 OXYGEN SATURATION DECREASED 2 0.0000
936 RHEUMATOID ARTHRITIS 4 0.0000
937 SOMNOLENCE 7 0.0000
938 LETHARGY 2 0.0000
939 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
940 DRUG WITHDRAWAL SYNDROME 3 0.0000
941 BONE PAIN 2 0.0000
942 BLADDER CANCER 2 0.0000
943 IRRITABILITY 2 0.0000
944 DRUG ADMINISTRATION ERROR 1 0.0000
945 ADVERSE EVENT 3 0.0000
946 FEMUR FRACTURE 1 0.0000
947 BONE DENSITY DECREASED 1 0.0000
948 CYSTITIS 1 0.0000
949 HIP FRACTURE 1 0.0000
950 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
951 DEVICE MALFUNCTION 2 0.0000
952 CEREBRAL HAEMORRHAGE 1 0.0000
953 MOBILITY DECREASED 2 0.0000
954 HYPERGLYCAEMIA 1 0.0000
955 UNDERDOSE 2 0.0000
956 ACCIDENTAL OVERDOSE 1 0.0000
957 DYSURIA 1 0.0000
958 DYSGEUSIA 2 0.0000
959 THROMBOCYTOPENIA 3 0.0000
960 HALLUCINATION 2 0.0000
961 UNEVALUABLE EVENT 2 0.0000
962 COLITIS 1 0.0000
963 DIABETES MELLITUS 2 0.0000
964 ANAEMIA 5 0.0000
965 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
966 ABNORMAL BEHAVIOUR 1 0.0000
967 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
968 BLINDNESS 1 0.0000
969 DEVICE LEAKAGE 1 0.0000
970 ANGIOEDEMA 1 0.0000
971 COLITIS ULCERATIVE 1 0.0000
972 DISEASE RECURRENCE 1 0.0000
973 COMA 1 0.0000
974 BLOOD GLUCOSE DECREASED 1 0.0000
975 AGGRESSION 1 0.0000
976 DRUG DEPENDENCE 3 0.0000
977 DEATH 15 0.0000
978 EXPOSURE DURING PREGNANCY 1 0.0000
979 DEVICE DIFFICULT TO USE 1 0.0000
980 DEHYDRATION 2 0.0000
981 PRODUCT QUALITY ISSUE 2 0.0000
982 OVERDOSE 3 0.0000
983 HOSPITALISATION 2 0.0000
984 CARDIAC FAILURE 1 0.0000
985 CARDIAC ARREST 1 0.0000
986 COMPLETED SUICIDE 1 0.0000
987 NO ADVERSE EVENT 2 0.0000